Katherine Vega Stultz is a seasoned biotech executive currently serving as an Independent Director at Kronos Bio, while leading as President and CEO of Ocelot Bio. With extensive experience in project and portfolio management at companies like Celgene and Eli Lilly, Katherine has a proven track record in developing innovative therapeutics and enhancing operational efficiencies. They also founded Keoe, providing strategic advisory services, and are the CEO and Board Director at BrainXell. Katherine holds a Bachelor of Science in Mechanical Engineering with a concentration in Biomedical Applications from Cornell University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices